ERBB2 and esophageal adenocarcinoma: HER2 overexpression found in other cancers, like esophageal adenocarcinoma, was shown to also have an inhibitory effect on autophagy, and treatment with the dual EGFR/HER2 inhibitor Lapatinib also induced autophagic flux in vitro [71].